A new target for potential treatments for blast phase myeloproliferative neoplasm (BP-MPN), one of the most aggressive forms ...

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

Mwende was diagnosed with stage 0 breast cancer during a routine check-up. She had no family history, no warning signs. She ...

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...

College of Pharmacy, Touro University, 1310 Johnson Lane, Mare Island, Vallejo, California 94592, and Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, California 94945 * To whom ...

One of the most promising approaches in cancer therapy is implementing next-generation sequencing (NGS) techniques to uncover actionable mutations that can be targeted in a tissue-agnostic fashion. In ...

Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free ...

Researchers at ASCO's annual meeting also discussed the importance of repeat biopsies to assess HER2 status after first-line ...

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...

AstraZeneca and Daiichi Sankyo’s drug extended survival by 30% compared to a widely used regimen, further establishing its ...

Despite significant advances in understanding the occurrence, progression and treatment of chronic lymphocytic leukemia (CLL), there remains a need to explore novel mechanisms and therapeutic ...